Social Links

Follow on Facebook Follow on TwitterFollow EiR on PinterestFollow EiR on Instagram

Xpert Access

×

Login To Get Involved!


Forgot your username?


Forgot your password?

×

Join Us At EiR Now!

DNRS Roof Banner

 

DNRS Interactive DVD Series & Seminars

Allergen-specific immunotherapy: an update on immunological mechanisms of action

 

 

 

Monaldi Arch Chest Dis. 2006 Mar;65(1):34-7.

 

Allergen-specific immunotherapy: an update on immunological mechanisms of action.

 

Ciprandi G, Marseglia GL, Tosca MA.

 

Dipartimento Patologie Testa-Collo, Azienda Ospedaliera Universitaria "San Martino", Genova, Italy. This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Specific immunotherapy (SIT) is the only treatment able to modify the natural history of the allergic subjects. Several aspects of the immunopathological response modified by SIT have been investigated; the first parameter historically studied was the production of allergen-specific antibodies. An increase of allergen-specific IgG4 and a decrease of IgE appear after SIT. A shift from Th2-polarized immune response toward Th1-oriented pattern has been reported after SIT. More recently, a crucial role for a subpopulation of T cells has been evidenced: T regulatory cells (Treg). Allergic patients have a defect of Tregs. SIT is able of inducing a specific Treg response. Sublingual immunotherapy is an alternative route of administration for SIT. Recent evidence shows that SLIT is also able of inducing a Treg response as detected by IL-10 production.

 

Publication Types:
Review

 

PMID: 16700191 [PubMed - indexed for MEDLINE]

 


 

 

Related Articles:

 

Home Testing & Sanitizer:
 

 

 

 

 

ADVERTISEMENT

 

  • No comments found

Leave your comments

Post comment as a guest

0 Character restriction
Your text should be more than 25 characters
Your comments are subjected to administrator's moderation.
terms and condition.

Adsense Responsive BottomBanner